Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastroenterol. Nov 7, 2015; 21(41): 11552-11566
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11552
Table 2 Genetic polymorphisms associated with the outcomes of hepatitis C virus infection
GeneRisk alleleAssociationPopulationRef.
Lipid metabolism
APOB-516 CIncreased susceptibility of HCV infectionChinese[125]
APOEAPOE*3Viral persistenceNorthern European[126]
LDLrrs2738459 C, rs2569540 G, rs1433099 A, rs11672123 AHigher viral load in genotypes 1 and 4Spanish[127]
MTTP-493 THigher degree of steatosis, HCV RNA serum levels and hepatic fibrosisNative Italian[128,129]
PNPLA3M148Higher risk for steatosis and fibrosis progressionEuropean: Belgian, German and French[130]
Inmune response mediators
CXCL1rs4074 AHigher risk for LCGerman[131]
IL-28Brs12979860 THigher risk for LC and HCCNative Italian and Chinese[132,133]
TGF-β1-509 THigher risk for LC and HCCEgyptian[134]
TNF-α-308 AHigher risk for LC and HCCEgyptian[134]
Fibrogenesis
MMP-1-1607 2GHigher prevalence of LCJapanese[135]
MMP-3-1171 5ALower age at LC diagnosis and a higher Child-Pugh scoreJapanese[135]
MMP-9-1562 CHigher prevalence of LCJapanese[135]
Nutrient metabolism
MTHFR677 THyperhomocysteinemia and higher degree of steatosis and fibrosisItalian[136]
HFE63 DHigher likelihood of LCTaiwanese[137]
VDRCAA haplotype (rs1544410 C, rs7975232 A, rs731236 A)Higher fibrosis progression and LCSwiss[138]